Cardiology Flashcards
Low Dose ASA for CVD and CRC
adults 50-59 years with ASCVD risk of 10% and no increased risk of bleeding
HFrEF - mechanism & cause
impaired contractility
CAD/ischemia
HFpEF - mechanism & cause
stiffed LV w/ abnormal relaxation
HTN, aging, obesity, DM, CAD
HFrEF - therapy for all (symptomatic or asymptomatic)
ACE/ARB + BB
HFrEF- ARNI (valsartan/sacubrintril)
for chronic HFrEF who tolerate ACE/ARB
HFrEF - Aldosterone Antagonists
- symptomatic HF (III-IV)
- after acute MI
Ivabradine
sinus node monitor
for HFrEF III-IV with EF <35%, sinus rhythm and HR >70
max dose of BB
HFrEF - Isosorbide Dintrate-Hydralazine
symptomatic HF intolerant to ACEI/ARB
AA with III-IV HF
Implantable Cardioverter-Defebrillators in HF
EF <35%, II or III
only in IV if transplant candidate or LVAD
Cardiac Resynchronization Thearpy in HF
EF <35%, II-IV
sinus rhythm with either LBBB or QRS >150
Phlebotomy in CHD Patients
Hct >65% + symptoms
Anterior Infarct EKG
V3-V4
Septal V1-V2
Lateral Infarct EKG
I, aVL, V5-V6
Inferior Infarct EKG
II, III, aVF; need right sided EKG!
Posterior Infarct EKG
St depressions V1-V4
ST elevations in inferior or lateral leads
Initial Therapy for all ACS
Aspirin, Antiplatelet, nitrates, heparin
Initial Therapy within first 24 hours for ACS
BB
Statin
ACEI, ARB, aldosterone antagonist if indicated
Clopidogrel use in ACS
preferred agent if thrombolytic therapy is performed
Ticagrelor use in ACS
preferred therapy for STEMI, NSTEMI
AE: dyspnea
Prasugrel use in ACS
preferred in PCI performed
not for those older than 75 or history of TIA or stroke
Treatment for Left Ventricular Apical Thrombus
anticoagulation with warfarin for 3 months
Treatment of right ventricular infarction
bolus, positive inotropes (dopamine, dobutamine)
Free Wall Rupture Symptoms
sudden CP, syncope –> PEA
Rx sugery/pericardiocentesis
Acquired VSD after MI
septal wall rupture, usually within 3-5d
holosystolic murmur at LLSB